Article Details
Retrieved on: 2025-04-25 16:44:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the use of Alzheimer's drugs donanemab and lecanemab, which are anti-amyloid antibodies targeting amyloid plaques in the brain, slowing cognitive decline in patients with mild cognitive impairment. Tags relate to Alzheimer's disease and associated treatment and diagnostic methods.
Article found on: newsroom.uw.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here